| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Avidity Biosciences, Inc. (RNA) has 13 insiders with recent SEC Form 4 filings, including 0 buys and 14 sells. RNA is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 283.4K | $3.67M | - | |
| Other | 205.0K | $2.65M | - | |
| Other | 116.9K | $1.51M | - | |
| Other | 91.6K | $1.19M | - | |
| Other | 79.0K | $1.02M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Mar 12, 2024 | Boyce Sarah | President And CEO | Sale+OE | 112,000 | $21.70 | $2,430,391.60 | -33.3% | |
| Mar 1, 2024 | Boyce Sarah | President And CEO | Sale+OE | 84,000 | $20.13 | $1,691,306.40 | -42.8% | |
| Jan 22, 2024 | Levin Arthur A | Director | Sell | 1,859 | $10.13 | $18,831.67 | -9.6% | |
| Jan 22, 2024 | Boyce Sarah | President And CEO | Sell | 5,092 | $10.13 | $51,581.96 | -10.4% | |
| Jan 22, 2024 | Flanagan W. Michael | Csto | Sell | 4,129 | $10.13 | $41,826.77 | -10.3% | |
| Jan 22, 2024 | McCarthy Teresa | Chief Human Resources Officer | Sell | 2,065 | $10.13 | $20,918.45 | -10.8% | |
| Jan 22, 2024 | MacLean Michael F | Chief Financial Officer | Sell | 1,616 | $10.13 | $16,370.08 | -8.7% | |
| Mar 15, 2023 | Levin Arthur A | Director | Sale+OE | 100 | $22.01 | $2,201.00 | -0.5% | |
| Feb 14, 2023 | Levin Arthur A | Chief Scientific Officer | Sale+OE | 10,000 | $23.66 | $236,566.86 | -20.3% | |
| Feb 3, 2023 | Boyce Sarah | President And CEO | Sale+OE | 50,000 | $24.35 | $1,217,726.80 | -23.8% |